Freedom to Operate for MedTech: FTO Search and Analysis Basics

2026-08-07 · Caduvo Team

Freedom-to-operate analysis tells you whether your medtech device infringes someone else’s patent. This guide covers when to run it, what it costs, and how to design around blocking claims.

MedTech startup funding rounds often go sideways for one avoidable reason: a patent that was never cleared. Not your patent. Someone else’s. Freedom-to-operate (FTO) analysis is the process of determining whether commercializing your device risks infringing enforceable third-party patent claims. It’s not a patentability opinion. It’s not a regulatory clearance. And it’s squarely on the startup to figure out before spending heavily on design, tooling, and clinical builds.

FTO vs. Patentability: Two Different Questions

Your patent counsel might tell you the device is patentable. That’s different from sellable. Patentability examines novelty and non-obviousness of your own invention. FTO asks: Does making, using, or selling your device step on someone else’s in-force patent? A novel coating on a catheter may be patentable, but if the underlying catheter assembly is covered by an unexpired utility patent, you’ll need a license or a design-around. The two analyses answer different questions, and both are necessary. Confusing them leads to expensive mistakes.

What an FTO Search Actually Covers (Hint: It’s Not Abstracts)

An FTO search digs into issued patent claims—the numbered statements that define the legal monopoly—not abstracts, titles, or marketing summaries. Claims are what a court looks at. For a U.S.-focused medtech startup, the primary search targets U.S. utility patents and published applications that could still issue. Design patents matter only if the ornamental shape is non-functional. The search often extends to key manufacturing or export jurisdictions.

Professional searches start with patent classification codes (CPC) and keyword strategies tailored to the device’s components and method of use. Attorneys then map specific claim elements against your product’s technical specifications. For example, if a claim recites “a catheter assembly comprising a tubular body, a balloon positioned at a distal end, and a valve mechanism that…” and your device includes every one of those elements, infringement may exist. A quick Google Patents or USPTO keyword scan can raise red flags early, but it’s not a substitute for a claim chart and legal opinion.

When to Run an FTO Analysis in the Product Lifecycle

Run a preliminary landscape search once the product concept solidifies. That surface-level scan flags crowded areas and obvious blocking patents. A formal FTO analysis should happen after the design is substantially frozen but before committing to expensive tooling, verification builds, or clinical trial units. For a device using a predicate device for a 510(k) submission, the FTO timeline aligns with locking in the substantial-equivalence comparison; the design is set at that point. Discovering a blocking patent after FDA clearance doesn’t fix anything—the FDA doesn’t review patent rights. Many founders assume a cleared predicate means the patent landscape is clear. It doesn’t. Regulatory clearance and patent infringement are entirely separate.

Waiting until a fundraising due diligence request forces the issue can derail a round. Early FTO work gives you time to design-around or license before the sunk cost gets too high.

What Does an FTO Search Cost?

Expect to spend between $5,000 and $30,000 for a proper FTO search and opinion letter, depending on complexity. A simple mechanical instrument with a few components may land at the lower end. A system with embedded software, algorithms, and sensors across multiple patent families will cost more. A phased approach works well: allocate $2,000–$5,000 for an initial landscape report that identifies high-risk patents, then commission a targeted legal opinion on the final design. Budget for it in your seed round. The cost of a freedom-to-operate analysis for a medtech startup is modest compared to the cost of a redesign or litigation later.

If You Find a Problem: Design-Around Strategies

If the FTO uncovers a problematic patent, you have four primary paths:

• Design-around. Alter the device so it no longer practices every element of the asserted claim. This must avoid literal infringement and infringement under the doctrine of equivalents. Even small mechanical or material changes can be effective if guided by patent counsel.
• Invalidate the patent. If you have strong prior art, an inter partes review (IPR) at the USPTO can challenge validity. It’s expensive and not guaranteed, but may be viable if the patent is weak.
• License the patent. Negotiate a royalty-bearing license. This adds to unit cost but may be the fastest path to market if the technology is essential.
• Wait it out. Patent terms are 20 years from the earliest filing date. If the patent expires soon, you might time your market entry accordingly.

Actionable Takeaways

FTO analysis is not legal advice; always work with a qualified patent attorney. But here’s what you can do now:

• Separate patentability from freedom-to-operate early. They answer distinct questions.
• Start with a landscape search before design freeze to spot broad blocking patents.
• Budget at least $5–10k for an initial FTO opinion and include it in fundraising plans.
• Never assume a cleared 510(k) or CE mark means you’re free to sell. Regulatory clearance and patent rights are independent.
• Use claim mapping, not abstract reading, to assess risk.
• Pair your FTO timing with reimbursement pathway work. Platforms like Caduvo can map the coding, coverage, and payment side while your patent counsel handles the IP. A product that is patent-clear but non-reimbursable still won’t reach patients.